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Insulin-like growth factor I (IGF-I) rapidly (cl0 min) stimulated glucose uptake into myotubes of the L6 muscle cell line, al concemrdtions that 
act specifically on IGF-I receptors. Uptake remained stimulated at a steady level for l-2 h, after which a second stimulation occurred. The first 
phase was insensitive to inhibition of protein synthesis, Subcellular f actionation demonstrated that it was accompanied bylranslocalion ofgluwse 
transporters (both GLUTI and GLUM) to the plasma membrane from intracellular membranes. Trdnslocation sufficed lo explain the first phase 
increase in glucose transport, and there was no change in the total cellular content of GLUT1 or GLUT4 glucose transporters. The second phase 
of stimulation was inhibitable by cyclohcximidc, and involved a net increase in either GLUTI or GLUT4 transporter conlcnt, which was reflected 
in an increase in transporter number in plasma membranes. These results define a cellular mechanism of metabolic action of IGF-I in muscle cells; 
furthermore, they suggest that IGF-I has acute metabolic effects that mimic those of insulin, bypassing action on the insulin receptor. 
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1 a INTRODUCTION 
Insulin-like growth factor I (IGF-I) is a potent 
growth factor [I] inducing both muscle growth and dif- 
ferentiation [2]. These effects are extremely important 
during fetal maturation, but also during post-natal 
growth and for muscle regeneration. Recently, effects of 
IGF-I other than its growth and differentiation promot- 
ing actions were recognized, specifically the ability to 
lower glycemia when perfused in rats [3] or dogs [4]. 
This effect was associated with enhanced glucose 
utilization by skeletal muscle [4] and indeed was 
reflected in increased hexose uptake by muscles in vivo 
[5]. This metabolic effect of IGF-I is specific and in- 
dependent of actions on the insulin receptor, and it has 
been proposed that IGF-I stimulation of glucose uptake 
can bypass insulin resistance in certain animal models 
of diabetes [3,6]. The molecular mechanism underlying 
such stimulation of glucose influx into muscle is un- 
known. In the present study we examined the effect of 
acute (5-45 min) and prolonged (2-8 h) effects of IGF-I 
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on glucose transport and glucose transporters (subcel- 
lular distribution and biosynthesis) in differentiated Lci 
muscle cells in culture. 
2. EXPERIMENTAL 
2.1. Celi cdtrrrcs, ifwubariorrs and h~tw5e uprukkc assu_ss 
A clonally selected line of L6 muscle cells (selected for high fusion 
potential into myotubes) was grown in culture and allowed to fuse and 
diffcrcniiate, essentially as reported earlier [ql. Cells were studied at 
the myotubc stage, when r90% fusion was attained. Monolayer cul- 
tures of myotubes in 3.5 cm diameter wells wcrc incubated for 5 h in 
aMEM containing 25 mM D-glucose in the abgnce of serum. This 
results in low and steady basal glucose uptake ralcs [S]. Human recom- 
binant IGF-I was then added at the indicated concentrznions and for 
the indicated times, at 37OC, followed by removal of the medium and 
assay of hexose (2-deoxy-o-glucose) transport as dcscribcd earlier [9], 
Under the conditions of the assay (5 min, IO yM hcxosc) lranspon is 
rate limiting over phosphorylation [9]. Non-carrier-mediated hexose 
uptake was measured in parallel as the cytochalasin B-insensitive 
component and was subtracted from all measurements. 
2.2. Mmtbrunc isokdorr 
Total membranes from L6 myotubes were prepared as described 
earlier 171. Plasma membranes (PM) and intracellular light micro- 
somes (IM) were isolated by a modification of a previously published 
procedure [IO] as follows: cells of twelve IO cm dishes of L6 myolubes 
in incubation medium were gently scraped with a rubber policeman. 
centrifuged (700 x 6 for 10 min), tte cdl pellet was resuspended in 16 
ml of ice-cold buffer I (250 mM sucrose, 20 mM HEPES, pH 7.4.2 
mM EGTA. 3 mM NaN, containing freshly added protease inhibitors: 
200 @I PMSF, I fiivE Ieupeplin. i p&t p2pstadn A, :CpM E-54) ;I%! 
homogenized in a 40 ml glass Dounce type A homogenizer (20 
strokes). All subsequent steps were conducr.Lrl at 4°C. The homo- 
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genatc was centrifuged at 700 x s for 5 min and the resultant supcr- 
natant (SNI) was collected and set on ice. The prllci (PI) was rc- 
suspended in 8 ml of buffer I and re-homogenized followed by 700 x 
g 5 min centrifugation. Pellet P2 was discarded, and supernatants SN2 
and SNI were pooled and centrifuged at 31,000 x g for 60 min. 
Supernatant SN3 was used to collect IM by centrifugation at 177,000 
xx for GO min ond resuspension i O.5 ml bulTer I. Thc31,000xgpellct 
(P3) was rcsuspznded in buffer I to 3 ml using a Whcaton 5 ml teflon 
on glass homogenizer. and layered on a discontinuous sucrose 
gradient (32% w/w, 40% w/w and 50% w/w, in 20 mM HEPSS, pH 
7.4, 3 ml each). After centtifugation at 210,000 x g for 2.5 h, 
membranes were collected through the side of the gradient ube by 
puncture with a syringe from the 32% layer and 32%/40% and 4O%l 
50% interfaces. Each fraction was diluted ?O-fold with 5 mM HEPES, 
pH 7.4. centrifuged at 31,000 xg for 60 min and resuspended in 0.5 
ml buffer I. Membrsue protein wus de termined by the bicinchoninic 
acid method (Pierce). To prepare total membranes (TM), the mixture 
SN I +SN2 was centrifuged at 177,000 x g for 60 min. 
The PM, identiflcd by their enrichment in01 NaX ATPasc subunit 
and retention of label after biotinylation of intact cells, were found 
only on the 32% sucrose layer (see Results). tM were largely depleted 
of al Na/K ATPasc and did not retain biotin label. Biotinylation was 
carried out by labelling whole cells with NHS-LC-biotin (Pierce), and 
detection on Western blots usingavidin-coupled alkalinephosphatase. 
GLUT1 und GLUT4 glucose transporter isoforms were detected by 
Western blot analysis essentially 8s described earlier [7] using C- 
terminus specific antibodies to each isoform (RaGLUTRAMS and 
RalRGT, respectively, from East Acres Biologicals). al Na/K ATP- 
asc was detected with hybridomaculture supcrnatant (1:lOO) contain- 
ing the isozyme-specific monoclonal ntibody McKl and I?- labclled 
sheep anti-mouse IgG (0. I ycilml). Statistic analysis was by Student’s 
f-test. 
3. RESULTS AND DISCUSSION 
3.1. Dose-dependence and time-course of IGF-l stimula- 
tiott of hexose transport 
Fig. 1A shows a representative IGF-I dose-response 
curve of the stimulation of 2-deoxyglucose uptake in L6 
myotubes exposed to the growth factor for 45 min. 
Maximal stimulation was -300% above basal transport, 
and it was attained with 1-3 nM IGF-I. Half-maximal 
stimulation was obtained with 0.1 nM IGF-I* These 
concentrations are far lower than those at which IGF-I 
interacts with the insulin receptor in LB muscle cells 
[I 1,121. L6 muscle cells have been shown to express 
IGF-I receptors [i 1,131 and insulin receptors ([12] and 
R.J. Smith, personal communication). Based on binding 
and immunoprecipitation studies in WGA-purified 
membrane proteins, an insulin receptor with high affln- 
ity for IGF-I [13] was also proposed to exist in these 
cells. However, since 10 nM IGF-I did not displace 
bound ‘z51-insulin from intact L6 cells at all, and 100 
nM IGF-I displaced only 10% of the bound insulin [ 111, 
*The dose-response curve does not fit a perfect sigmoidal curve. This 
could indicate that more than onc binding site is responsible fur 
stimulation of glucose transport. Aliernatk;ely, rhc shape of the curve 
may be governed by the amplification process of the IGF-I signalling 
pathway. 
P 
15 
10 
14 pla 
P 
0 
5 q 
.I4 -13 -12 -11 -9 *9 -10 ' 
log[IGF-I], M 
._- 
B 
100 I. I - 1 - I - 
0 100 200 300 400 , 
time (mln) 
IO 
Fig. I. (A) Dose-response curve of the stimulation of 2-dcoxy_D- 
glucose uptake by IGF-I. L6 myotubes were prcsincubated for 5 h in 
aMEM containing 2s mM glucose in zbscnce of serum, and then 
exposed to the indicated concentrations of IGF-I and 5 mg/ml BSA 
in the above medium for 45 min, This was followed by rapid rinsing 
and determination of initial rates of carrier-mediated 2-deoxy-o- 
glucose uptake in HEPES-buffered saline solution (set Experimental). 
Results are the mean of six replicates inone experiment representative 
of4 with average maximal stimulation of 210?30% and average EDs, 
of 0.0710.03 nM. (B) Time-course of IGF-I action on 2-deoxy-o- 
glucose uptake. Incubations were as in A except hat cells were cx- 
posed to IO nM IGF-I for the indicated time periods. Results are the 
mean of three replicates in one experiment representative of 3. 
it can be considered that, at concentrations at or below 
10 nM, IGF-I is bound exclusively to the IGF-I receptor 
and not to the classical insulin receptor. 
Fig, 1B illustrates the time-course of stimulation of 
hexose uptake by 10 nM IGF-I. Surprisingly, the 
growth factor had a temporal bimodal effect: a rapid 
stimulatory phase was completed in 10 min, followed by 
a plateau period and a secondary stimulatory phase 
after l-2 h which lasted for up to 8 h. The second phase 
was net due to a glucose-deprivation effect caused by 
glucose exhaustion from the medium, since similar 
results were observed when the medium was changed 
286 
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Fig, 2. Effect ofcyclohcximide on the early and late phases of IGF-I stimulation of hcxose transport. LB myotutxswerc prc-incubated inserum-fra 
aMEM containing 25 mM glucose for 4.5 h, followed by a 30 min incubation in the absence or presence of Syglml cyclohcximidc (CHX). Incubation 
with 3 nM IGF-I followed, in otherwise the same media, for (A) 45 min or (l3) 8 h. Hexosc uptake was subscqurntly determined as in Fig. IA. 
Results arc the mean of six replicates in one experiment representative of2, expressed as % of basal uptake. CHX (Spg/ml) lowcrcd 35[S]nuthioninc 
incorporation into protein to 6% of its value in control cells. 
several times during the 8 h incubation (not shown). The 
fast stimulatory phase was not inhibited by pre-incuba- 
tion with the protein synthesis inhibitor cyloheximide 
(Fig. 2A), whereas the second stimulation was largely 
prevented by this treatment (Fig. 2l3). Thus, the second 
stimulntory phase depends on protein synthesis. 
3.2. The rapidphase: recruittrretu ofglucose trunsporters 
The mechanism underlying the fast phase was inves- 
tigated by assaying the content of glucose transporter 
isoforms in subcellular membrane fractions (PM and 
IM). L6 myotubes were previously shown to express 
both the GLUT1 and GLUT4 isoforms of glucose 
transporters [7,14]. Subcellular fractions were isolated 
as described in Experimental. The purity of the 
membrane fractions was confirmed by an enrichment in 
al Na/K ATPase (a plasma membrane marker) in the 
PM but not in the IM relative to TM. Western blot 
analysis of GLUT1 and GLUT4 transporter content 
are illustrated in Fig. 3A. The GLUT1 isoform was 
more abundant in the PM than in the IM, whereas the 
reverse was true for the GLUT4 isoform. IGF-I treat- 
ment (10 nM for 45 min) prior to subcellular fractiona- 
tion resulted in a gain in GLUT1 transporters in the PM 
fraction and a concomitant loss in the IM fraction. A 
qualitatively similar observation was made for the 
GLUT4 isoform. These results suggest hat both iso- 
forms translocate from the IM to the PM in response 
to the growth factor. The specificity of this response was 
underscored by the lack of change in content of al 
Na/K ATPase subunit in response to cellular treatment 
with IGF-I (Fig. 3A). The other membrane fractions 
isolated by the subcellular fractionation procedure are 
membranes banding atop 40% and 50% sucrose. 
Glucose transporters were present at a low level in these 
fractions, but importantly neither fraction showed a 
change in GLUT1 or GLUT4 content in response to 
IGF-I (not shown). Fig. 3B presents the results of 7 
Western blot studies of GLUT1 analogous to that ii- 
lustrated in Fig. 3A, quantitated by laser scanning den- 
sitometry. Fig. 3C shows the equivalent results of 
GLUT4 immunoreactivity. The results are in arbitrary 
densitometric units per mg protein in each fraction. It 
can be appreciated that IGF-I caused a 1.22+0.09-fold 
increase in GLUT1 protein (PcO.005) and a 1.27f0.10- 
fold increase in GLUT4 protein (PcO.001) in the PM, 
and both isoforms decreased significantly in the IM 
fraction (PcO.025 for both isoforms), whereas al NalK 
ATPase in the PM was not significantly affected 
(1.04f0.2). In contrast, neither GLUT1 nor GLUT4 
content changed in the TM of IGF-I treated (45 min) 
cells. 
o-Glucose-protectable binding of cytochalasin B is a 
recognized quantitative measurement of glucose trans- 
porters, and this approach was used to calculate the 
actual number of pmol of glucose transporters in the 
membrane fractions, irrespctive of their isoform. in 
experiments not shown, we observed that the% increase 
in cytochalasin B binding in the PM fraction closely 
matched the% increase in hexose transport caused by 
287 
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Fig. 3. (A) Rapid effect of IGF-I on GL’JTI and GLUT4 glucose transporters. L6 myotubcs wcrc serum-depleted for 16 h in aMEM containing 
25 mM glucose, then incubated without (&min;) or with (+j 10 nM 1GP-I for 43 min. Purified plasma membranes (PM) and intracellular light 
microsomes (IM) were prepared and GLUTI and GLUT4 glucose transporters were detected by Western blot analysis as described inExperimental. 
The content of immunorcactive al Na/K ATPase subunit in each gel is given for assessment of membrane purity and specificity of IGF-I action. 
(B anti C) Densitometric analysis of 7 experiments (mcan+S.E.M,) similar to that illustrated in Fig. 3A. The content in control PM was assigned 
a value of I .O and other values are expressed in relative units. 
IGF-I. These results indicate that translocation of 
glucose transporters alone may suffice to account for 
the rapid stimulation of transport activity caused by the 
growth factor. Such a comparison cannot be made from 
Western blot analysis of the individual isoforms, since 
the actual amount of each transporter isoform cannot 
be quantitated on a molar basis. 
3.3. The second pltase: synthesis of glucose trunsporters 
The second (protein synthesis-dependent) phase of 
stimulation of hexose transport by IGF-I was also in- 
vestigated. In contrast o the observations made of the 
rapid stimulatory phase, treatment with IGF-I for 8 h 
resulted in a gain in both GLUT1 and GLUT4 in TM 
(Fig. 4). Scanning densitometry of the fractions isolated 
from S experiments indicated that the increase in 
GLUT1 transporters was 1.2X0.1 I -fold (PcO.05) and 
the increase in GLUT4 transporters was 1.1 S-tO.OS-fold 
(P~0.05) in the Tivi (Fig. 4@). isolated membrane frac- 
tions showed that both GLUT1 and GLUT4 increased 
in the PM (by 1.92kO.13 and 1.25f0.17, respectively) 
without significant decrease in the IM (Fig. 4A,B). Since 
288 
the increase in the PM is higher for GLUT1 than for 
GLUT4, it is proposed that the stimulation of glucose 
transport by long-term exposure to IGF-I is largely due 
to the presence in the PM of newly synthesized GLUT1 
transporters, and that the newly synthesized GLUT1 
transporters are mostly rou ted to the cell surface. 
In conclusion, IGF-I was here demonstrated to have 
acute and prolonged effects on glucose transport in 
muscle cells. These responses arose through different 
mechanisms. The rapid stimulatory phase was indepen- 
dent of ongoing protein synthesis and was due to 
recruitment of glucose transporters to the cell surface 
from an intracellular membrane organelle. This is simi- 
lar to the action of insulin in skeletal muscle in vivo 
[ 15,161 and in LG muscle cells [lo]. Recruitment involved 
both the GLUT1 and GLUT4 transporter isoforms. 
The slower phase was largely dependent on new protein 
synthesis, and involved increases in cellular content of 
GLL’Ti and GLUT4 transporters which raised the !ev- 
els of these transporters in the cell surface. This is sim- 
ilar to the effect of prolonged insulin treatment of L6 
cells, which elevated GLUT1 content biosynthetically 
Volume 298, number 2,3 FEBS LEITERS February 1992 
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Fig. 4. Latr effects of IGF-I on (A) GLUT1 and (B) GLUT4 glucose transporters. Incubations were as in Fig. 3 except hat exposure to IGF-I 
was for 8 h. Results are of 4 experiments, cxprcsscd as mcan+S.E.M. in units relative to the content in the control PM for each transporter. (C) 
Content o(‘GLUTl and GLUT4 proteins in total (unfractionatcd) mcmbrancs of 5 cxperimcnu. Control fractions were assigned a value of 1.0 
for each transporter. 
[9,14] and GLUT4 content through post-translational 
mechanisms [ 14,171. 
3.4. Nurure of the resportrling ~~pptor 
The above actions of IGF-I are not likely to be 
mediated by the classical insulin receptor in L6 cells, 
since the EDSo for stimulation of glucose transport by 
IGF-I was 0.1 nM, about two orders of magnitude 
lower than the EDS0 for insulin (28 nM). However, one 
cannot distinguish operationally whether IGF-I 
responses occur (i) through the atypical insulin receptor 
with very high affinity for IGF-I proposed by Burant 
et al. [13], or (ii) through a bona fide IGF-I receptor**. 
Regardiess of this uncertainty, it remains clear that 
**There is presently no jiincrional evidence for the existence of an 
abnomlal insulin receptor binding IGF-1 with high affinity in intact 
L6 cells. Hybrid receptors remain a viable explanation for the resulls 
observed in hmmunopreoigitated r ceptor studies. Resolution of the 
two alternatives stated would require selective inhibition of the classi- 
cal IGF-I receptor with a non-penetrating, specific probe such as an 
anti-IGF-I receptor antibody that could block IGF-I binding to intact 
rat cells. Such antibodies arc currently unavailable. 
IGF-I can elicit responses through receptors that bind 
IGF-I other than the typical insulin receptor. It is specu- 
lated that defects in insulin action that involve binding 
to and signalling from the insulin receptor could poten- 
tially be bypassed by judicious administration of IGF-I. 
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